1-1 of 1
Jakob Thaning Bay, MD PhD
Close
Sort by
Journal Articles

Combined Ibrutinib and Venetoclax Changes Myeloid Phenotype and Improves Immune Function in CLL Patients

Rebecka Svanberg, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Jakob Thaning Bay, MD PhD, Lars Peter Ryder, MSc, PhD, Hanne Vibeke Vibeke Marquart, Arnon P Kater, MD PhD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4289.
https://doi.org/10.1182/blood-2019-123410
Published: 2019